Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Annual report

4594.TEDINET S100PTKG
Period2017-04-01 → 2018-03-31
Filed2022-12-19
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed

Amends S100D9WP.

Key figures · 108
MetricValuePeriodScopeSource row
Revenue¥354m2017-04-01 → 2018-03-31Cons.Net sales
Revenue¥530m2016-04-01 → 2017-03-31Cons.Net sales
Operating income−¥1.6bn2017-04-01 → 2018-03-31Cons.Operating income
Operating income−¥1.1bn2016-04-01 → 2017-03-31Cons.Operating income
Ordinary income−¥1.6bn2017-04-01 → 2018-03-31Cons.Ordinary income
Ordinary income−¥1.1bn2016-04-01 → 2017-03-31Cons.Ordinary income
Profit before tax−¥1.6bn2017-04-01 → 2018-03-31Cons.Income before income taxes
Profit before tax−¥1.1bn2016-04-01 → 2017-03-31Cons.Income before income taxes
Net income (owners)−¥1.6bn2017-04-01 → 2018-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.1bn2016-04-01 → 2017-03-31Cons.Profit loss attributable to owners of parent
Net income−¥1.6bn2017-04-01 → 2018-03-31Cons.Profit loss
Net income−¥1.1bn2016-04-01 → 2017-03-31Cons.Profit loss
Total assets¥7.2bnat 2018-03-31Cons.Assets
Total assets¥5.4bnat 2017-03-31Cons.Assets
Total liabilities¥285mat 2018-03-31Cons.Liabilities
Total liabilities¥207mat 2017-03-31Cons.Liabilities
Net assets / equity¥7.0bnat 2018-03-31Cons.Net assets
Net assets / equity¥5.2bnat 2017-03-31Cons.Net assets
Net assets / equity¥2.7bnat 2016-03-31dCons.Net assets
Cash and deposits¥6.5bnat 2018-03-31Cons.Cash and deposits
Cash and deposits¥5.0bnat 2017-03-31Cons.Cash and deposits
Cash & equivalents¥6.5bnat 2018-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.0bnat 2017-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2016-03-31dCons.Cash and cash equivalents
Operating cash flow−¥1.6bn2017-04-01 → 2018-03-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥1.1bn2016-04-01 → 2017-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥112m2017-04-01 → 2018-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥97m2016-04-01 → 2017-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥3.3bn2017-04-01 → 2018-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥3.6bn2016-04-01 → 2017-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-41.252017-04-01 → 2018-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.742016-04-01 → 2017-03-31Cons.Basic earnings loss per share (5-year summary)
Net assets per share¥164.78at 2018-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥139.17at 2017-03-31Cons.Net assets per share (5-year summary)
Equity ratio95.3%at 2018-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio95.8%at 2017-03-31Cons.Equity to asset ratio (5-year summary)
Employees42at 2018-03-31Cons.Number of employees
Employees37at 2017-03-31Cons.Number of employees
Revenue¥354m2017-04-01 → 2018-03-31StandaloneNet sales
Revenue¥530m2016-04-01 → 2017-03-31StandaloneNet sales
Revenue¥823m2015-04-01 → 2016-03-31dStandaloneNet sales (5-year summary)
Revenue¥822m2014-04-01 → 2015-03-31dStandaloneNet sales (5-year summary)
Revenue¥933m2013-04-01 → 2014-03-31dStandaloneNet sales (5-year summary)
Operating income−¥1.5bn2017-04-01 → 2018-03-31StandaloneOperating income
Operating income−¥1.1bn2016-04-01 → 2017-03-31StandaloneOperating income
Ordinary income−¥1.6bn2017-04-01 → 2018-03-31StandaloneOrdinary income
Ordinary income−¥1.1bn2016-04-01 → 2017-03-31StandaloneOrdinary income
Ordinary income−¥993m2015-04-01 → 2016-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥414m2014-04-01 → 2015-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥19m2013-04-01 → 2014-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.6bn2017-04-01 → 2018-03-31StandaloneIncome before income taxes
Profit before tax−¥1.1bn2016-04-01 → 2017-03-31StandaloneIncome before income taxes
Net income−¥1.6bn2017-04-01 → 2018-03-31StandaloneProfit loss
Net income−¥1.1bn2016-04-01 → 2017-03-31StandaloneProfit loss
Net income−¥994m2015-04-01 → 2016-03-31dStandaloneNet income loss (5-year summary)
Net income−¥412m2014-04-01 → 2015-03-31dStandaloneNet income loss (5-year summary)
Net income¥17m2013-04-01 → 2014-03-31dStandaloneNet income loss (5-year summary)
Total assets¥7.2bnat 2018-03-31StandaloneAssets
Total assets¥5.4bnat 2017-03-31StandaloneAssets
Total assets¥2.9bnat 2016-03-31dStandaloneTotal assets (5-year summary)
Total assets¥1.2bnat 2015-03-31dStandaloneTotal assets (5-year summary)
Total assets¥397mat 2014-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥287mat 2018-03-31StandaloneLiabilities
Total liabilities¥204mat 2017-03-31StandaloneLiabilities
Net assets / equity¥7.0bnat 2018-03-31StandaloneNet assets
Net assets / equity¥5.2bnat 2017-03-31StandaloneNet assets
Net assets / equity¥2.7bnat 2016-03-31dStandaloneNet assets
Net assets / equity¥1.0bnat 2015-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥189mat 2014-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.5bnat 2018-03-31StandaloneCash and deposits
Cash and deposits¥4.9bnat 2017-03-31StandaloneCash and deposits
Cash & equivalents¥2.6bnat 2016-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥824mat 2015-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥90mat 2014-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥909m2015-04-01 → 2016-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥447m2014-04-01 → 2015-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥37m2013-04-01 → 2014-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥32m2015-04-01 → 2016-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥67m2014-04-01 → 2015-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4m2013-04-01 → 2014-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥2.7bn2015-04-01 → 2016-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.2bn2014-04-01 → 2015-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-41.252017-04-01 → 2018-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-32.742016-04-01 → 2017-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-35.282015-04-01 → 2016-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-20.62014-04-01 → 2015-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥1.462013-04-01 → 2014-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥164.78at 2018-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥139.17at 2017-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥85.53at 2016-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥30.74at 2015-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4.53at 2014-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio95.2%at 2018-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio95.8%at 2017-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio94.6%at 2016-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.4%at 2015-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio46.5%at 2014-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE10.0%2013-04-01 → 2014-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued41,835,400at 2018-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued37,218,400at 2017-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued31,807,700at 2016-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued210,649at 2015-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued97,015at 2014-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees42at 2018-03-31StandaloneNumber of employees
Employees37at 2017-03-31StandaloneNumber of employees
Employees21at 2016-03-31dStandaloneNumber of employees
Employees19at 2015-03-31dStandaloneNumber of employees
Employees16at 2014-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 927
ItemContextValueUnit
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember_CapitalStockMember1645517000JPY
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember_LegalCapitalSurplusMember1645517000JPY
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember_CapitalSurplusMember1645517000JPY
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember3291035000JPY
Issuance of new sharesCurrentYearDuration_NonConsolidatedMember3291035000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-1577142000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember_RetainedEarningsMember-1577142000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember-1577142000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember-1577142000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember36803000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember36803000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_CapitalStockMember1645517000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_LegalCapitalSurplusMember1645517000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_CapitalSurplusMember1645517000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-1577142000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_RetainedEarningsMember-1577142000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember1713892000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember36803000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember1750696000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_CapitalStockMember5419931000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_LegalCapitalSurplusMember5403516000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_CapitalSurplusMember5403516000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember-3929896000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_RetainedEarningsMember-3929896000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember6893551000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember57019000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember6950570000JPY
Directors compensations sgaPrior1YearDuration_NonConsolidatedMember67550000JPY
Directors compensations sgaCurrentYearDuration_NonConsolidatedMember74400000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember41776000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember43332000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember1659000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember1283000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember3271000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember3448000JPY
Compensations sgaPrior1YearDuration_NonConsolidatedMember30297000JPY
Compensations sgaCurrentYearDuration_NonConsolidatedMember33822000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember801972000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember1146584000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書の訂正報告書（2022年12月19日付けの訂正報告書の添付インラインXBRL）
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-12-19
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第15期(自　2017年４月１日　至　2018年３月31日)
Company name cover pageFilingDateInstantText · Plus
Company name in english cover pageFilingDateInstantBrightPath Biotherapeutics Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　永井 健一
Address of registered headquarter cover pageFilingDateInstantText · Plus
Telephone number address of registered headquarter cover pageFilingDateInstant044-440-3939
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)管理部長　竹下 陽一

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 23 of 23 passed
balance sheet identityconsolidated 2017-03-31pass
balance sheet identityconsolidated 2018-03-31pass
balance sheet identitynon_consolidated 2017-03-31pass
balance sheet identitynon_consolidated 2018-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2017-03-31pass
statement vs summary · net assetsconsolidated 2018-03-31pass
statement vs summary · net assetsnon_consolidated 2016-03-31pass
statement vs summary · net assetsnon_consolidated 2017-03-31pass
statement vs summary · net assetsnon_consolidated 2018-03-31pass
statement vs summary · net income attributable to parentconsolidated 2016-04-01/2017-03-31pass
statement vs summary · net income attributable to parentconsolidated 2017-04-01/2018-03-31pass
statement vs summary · operating cash flowconsolidated 2016-04-01/2017-03-31pass
statement vs summary · operating cash flowconsolidated 2017-04-01/2018-03-31pass
statement vs summary · revenueconsolidated 2016-04-01/2017-03-31pass
statement vs summary · revenueconsolidated 2017-04-01/2018-03-31pass
statement vs summary · revenuenon_consolidated 2016-04-01/2017-03-31pass
statement vs summary · revenuenon_consolidated 2017-04-01/2018-03-31pass
statement vs summary · total assetsconsolidated 2017-03-31pass
statement vs summary · total assetsconsolidated 2018-03-31pass
statement vs summary · total assetsnon_consolidated 2017-03-31pass
statement vs summary · total assetsnon_consolidated 2018-03-31pass